haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid

Poland

Drugs containing this active substance

  • ACT-HIB

    It is used to prevent invasive diseases caused by the Haemophilus influenzae type b bacterium, such as meningitis, septicaemia, arthritis, or epiglottitis. It is intended for children from 2 months of age.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid 10 mcg

    ATC: J07AG01

    Manufacturer: Sanofi Pasteur